We are live on ! Find out more
HRMY icon

Harmony Biosciences
HRMY

147 hedge funds and large institutions have $1.9B invested in Harmony Biosciences in 2021 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

329% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 14

60% more capital invested

Capital invested by funds: $1.19B → $1.9B (+$714M)

44% more funds holding

Funds holding: 102 → 147 (+45)

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

29% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 31

21.95% more ownership

Funds ownership: 54.26% → 76.21% (+22%)

Holders
147
Holders Change
+45
Holders Change %
+44.12%
% of All Funds
2.26%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
60
Increased
40
Reduced
31
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$84.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$20.3M
3
State Street
State Street
Massachusetts
+$15.1M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.9M
5
American Century Companies
American Century Companies
Missouri
+$11.4M

Top Sellers

Rank Fund Capital Flow
1
NP
Newlight Partners
New York
-$39.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$17.6M
3
VP
venBio Partners
California
-$12.9M
4
PA
Perceptive Advisors
New York
-$10M
5
ACM
Aisling Capital Management
New York
-$9.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$8.5M +$5.22M +130,858 +191%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$8.32M +$6.33M +158,725 +436%
HP
28
HealthInvest Partners
Sweden
$8.31M +$399K +10,000 +5%
Morgan Stanley
29
Morgan Stanley
New York
$7.3M +$5.05M +126,623 +285%
Principal Financial Group
30
Principal Financial Group
Iowa
$6.76M +$6.32M +158,557 New
MB
31
MPM BioImpact
Massachusetts
$6.07M -$367K -9,213 -6%
RHJA
32
Rice Hall James & Associates
California
$5.87M -$62.5K -1,568 -1%
Renaissance Technologies
33
Renaissance Technologies
New York
$5.75M +$3.8M +95,400 +242%
BBA
34
Baker Bros. Advisors
New York
$5.27M – – –
BG
35
Bellevue Group
Switzerland
$5.17M -$324K -8,128 -6%
First Trust Advisors
36
First Trust Advisors
Illinois
$4.89M +$4.57M +114,625 New
Invesco
37
Invesco
Georgia
$4.71M +$4.02M +100,902 +1,067%
Ameriprise
38
Ameriprise
Minnesota
$4.03M +$3.76M +94,433 New
Citadel Advisors
39
Citadel Advisors
Florida
$3.86M +$1.97M +49,384 +120%
Wellington Management Group
40
Wellington Management Group
Massachusetts
$2.59M +$2.42M +60,694 New
CIBC Private Wealth Group
41
CIBC Private Wealth Group
Georgia
$2.56M – – –
SEI Investments
42
SEI Investments
Pennsylvania
$2.47M -$232K -5,824 -9%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$2.29M +$1.33M +33,492 +167%
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$2.28M +$2.13M +53,540 New
Legal & General Group
45
Legal & General Group
United Kingdom
$2.25M +$1.84M +46,191 +717%
PAMP
46
Polar Asset Management Partners
Ontario, Canada
$2.2M +$2.06M +51,600 New
Marshall Wace
47
Marshall Wace
United Kingdom
$2.09M +$1.36M +34,098 +229%
Goldman Sachs
48
Goldman Sachs
New York
$2M -$303K -7,610 -14%
Public Sector Pension Investment Board (PSP Investments)
49
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.98M +$1.85M +46,450 New
CSS
50
Cubist Systematic Strategies
Connecticut
$1.83M -$464K -11,633 -21%
1
2
3 4 5

HRMY Hedge Fund Activity: Q4 2021 in Review

147 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q4 2021, worth a combined $1.9B — up 60% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new HRMY positions and 14 closed out — a net gain of 46 holders — while 40 added to existing stakes and 31 trimmed.

The largest buyer was BlackRock, adding an estimated $84.7M. The largest seller was Newlight Partners, cutting an estimated $39.9M.

  • 147 institutional investors held Harmony Biosciences (HRMY) as of Q4 2021, up from 102 in Q3 2021.
  • Funds reported $1.9B of Harmony Biosciences stock for Q4 2021, up 60% quarter-over-quarter.
  • 60 funds opened new Harmony Biosciences positions in Q4 2021 and 14 closed out, a net change of +46 holders.
  • The largest Harmony Biosciences buyer in Q4 2021 was BlackRock, an estimated $84.7M added.
  • The largest Harmony Biosciences seller in Q4 2021 was Newlight Partners, an estimated $39.9M sold.

Based on aggregated 13F filings for Q4 2021.